Keyword Connections

head and neck squamous cell carcinoma

Journals

4

1 oncology letters

2 OncoTargets and therapy

3 auris, nasus, larynx

4 aids research and human retroviruses

Research Groups

0

No Research Group Connected

Bibliographies

35

1 novel immunotherapeutic approaches for head and neck squamous cell carcinoma

2 common mutations assay of kras and braf genes in patients affected with head and neck squamous cell carcinoma (hnscc)

3 Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the molecular feature of tumor-associated neutrophils of head and neck squamous cell carcinoma.

4 Advances and challenges in CAR-T cell therapy for head and neck squamous cell carcinoma.

5 Synthesis and preclinical investigation of Tc-p-SCN-Bzl-DTPA-cetuximab for targeting EGFR using head and neck squamous cell carcinoma (HNSCC) xenografts.

6 LINC00958-MYC positive feedback loop modulates resistance of head and neck squamous cell carcinoma cells to chemo- and radiotherapy in vitro.

7 Patterns of bone metastases from head and neck squamous cell carcinoma.

8 Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma

9 E6 Oncoproteins from High-Risk Human Papillomavirus Induce Mitochondrial Metabolism in a Head and Neck Squamous Cell Carcinoma Model.

10 Transcriptomic model-based lncRNAs and mRNAs serve as independent prognostic indicators in head and neck squamous cell carcinoma.

11 High Notch1 expression affects chemosensitivity of head and neck squamous cell carcinoma to paclitaxel and cisplatin treatment.

12 The synthesis and application of nano doxorubicin-indocyanine green matrix metalloproteinase-responsive hydrogel in chemophototherapy forhead and neck squamous cell carcinoma (International Journal of Nanomedicine, 2019, 14, (623-638), 10.2147/IJN.S191069)

13 Finding/identifying primaries with neck disease (FIND) clinical trial protocol: a study integrating transoral robotic surgery, histopathological localisation and tailored deintensification of radiotherapy for unknown primary and small oropharyngeal head and neck squamous cell carcinoma.

14 MAPKAPK2 plays a crucial role in the progression of head and neck squamous cell carcinoma by regulating transcript stability

15 External validation of sTWEAK as a prognostic noninvasive biomarker for head and neck squamous cell carcinoma.

16 Outcomes of curative (chemo)radiotherapy for patients with non-p16 positive head and neck squamous cell carcinoma who are borderline for curative treatment.

17 Associations among smoking, MGMT hypermethylation, TP53-mutations, and relapse in head and neck squamous cell carcinoma.

18 Does multiparametric imaging with F-FDG-PET/MRI capture spatial variation in immunohistochemical cancer biomarkers in head and neck squamous cell carcinoma?

19 Association of metabolic and genetic heterogeneity in head and neck squamous cell carcinoma with prognostic implications: integration of FDG PET and genomic analysis.

20 Sex determining region Y-box 2 is a prognostic factor for head and neck squamous cell carcinoma: Evidence from 11 published investigations

21 Head and neck squamous cell carcinoma in HIV, HBV and HCV seropositive patients - Prognosis and its predictors

22 Head and neck squamous cell carcinoma in HIV, HBV and HCV seropositive patients - Prognosis and its predictors

23 Sex determining region Y-box 2 is a prognostic factor for head and neck squamous cell carcinoma: Evidence from 11 published investigations

24 involvement of extracellular vesicles in the macrophage-tumor cell communication in head and neck squamous cell carcinoma.

25 second primary cancer in patients with head and neck squamous cell carcinoma: case report

26 (−)-gossypol inhibits growth and promotes apoptosis of human head and neck squamous cell carcinoma in vivo

27 rhoc mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma

28 radiotherapy potentiation with weekly cisplatin compared to standard every 3 weeks cisplatin chemotherapy for locoregionally advanced head and neck squamous cell carcinoma 

29 cancer stem cells in head and neck squamous cell carcinoma

30 jak kinase inhibition abrogates stat3 activation and head and neck squamous cell carcinoma tumor growth

31 molecular cross-talk between the nfκb and stat3 signaling pathways in head and neck squamous cell carcinoma

32 prognostic value of tumor-infiltrating lymphocytes for patients with head and neck squamous cell carcinoma

33 elevated znf703 protein expression is an independent unfavorable prognostic factor for survival of the patients with head and neck squamous cell carcinoma

34 high expression of leucine zipper-ef-hand containing transmembrane protein 1 predicts poor prognosis in head and neck squamous cell carcinoma

35 overexpression of the orotate phosphoribosyl-transferase gene enhances the effect of 5-fluorouracil in head and neck squamous cell carcinoma in vitro